Telomir Pharmaceuticals (TELO) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Telomir Pharmaceuticals Inc - to Submit Ind & Inad Application by Q4 2025, With Clinical Trials Planned for 2026
ReutersDec 23, 2024 07:04 ET
EXCLUSIVE: Telomir Pharmaceuticals Reports Potential Of Telomir-1 For Wilson's Disease
BenzingaDec 23, 2024 06:46 ET
Express News | Telomir Pharmaceuticals Shares Down 12.57% at $4.45 in Premarket Trade; White Diamind Research Says It Has a Strong Sell Rating on the Stock
ReutersDec 13, 2024 09:07 ET
Express News | Telomir Pharmaceuticals Announced It Raised $1M In Equity Funding Through Starwood Trust
BenzingaDec 12, 2024 08:39 ET
Telomir Pharmaceuticals Enters Into Stock Purchase Agreement
Seeking AlphaDec 11, 2024 17:58 ET
Telomir Pharmaceuticals Raises $1M At $7 Per Share In No-warrant, Restricted Common Stock Deal - Filing
BenzingaDec 11, 2024 17:11 ET

Comments

Jaguar8

Dec 23, 2024 06:31

NEWS

$Telomir Pharmaceuticals (TELO.US)$
Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease
Monday, 23rd December at 7:30 am
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ: TELO), or the "Company", an emerging leader in age-reversal science, today announced significant findings from its copper binding studies with Telomir-1. This is a promising development as the company explores Telomir-1 for the...

Jaguar8

Dec 12, 2024 07:32

NEWS

$Telomir Pharmaceuticals (TELO.US)$
Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price
Thursday, 12th December at 8:30 am
Transaction follows a $5 million non-dilutive credit line from the same trusted partner, further reinforcing Telomir's financial strength and growth potential.
MIAMI, FL / ACCESSWIRE / December 12, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ: TELO) ("Telomir" or the "Company"...

Jaguar8

Dec 11, 2024 21:35

🕒Watchlist THURSDAY 12/11. NFA. Trade the Chart, not emotions.

Please take note of the following acronyms
NFA = not financial advice
RTH = regular trading hours
AH = after hours
LTB = left to borrow
CTB = cost to borrow
*I removed $AmpliTech Group (AMPG.US)$ because it just announced direct offering of $2M valued $1.6/shares. Now there are offerings where market defies it and continues to rally. We shall see tomorrow
$Nuburu (BURU.US)$ PR AH 12/11: Resolved compliance issue. Up AH. Low float. CTB...

115

38

6

Trytosaveabit

Dec 11, 2024 17:07

Update

$Telomir Pharmaceuticals (TELO.US)$ On December 9, 2024, Telomir entered into a Stock Purchase Agreement with a certain accredited investor, pursuant to which the Company issued 142,857 shares of common stock at a price of $7 per share for a total of $1 million, a 20% premium to the closing price of the Company's common stock on the date of the transaction.
The transaction did not involve the issuance of any warrants. This transaction follows a $5 million non-dilutive line of credit extende...

1

MrSuperStonk

Sep 27, 2024 13:18

$Telomir Pharmaceuticals (TELO.US)$ telomir is a very interesting product. But if this is revolutionary has much has they claim... a bigger compagny could swoop in and prevent this from ever existing

TELO Telomir Pharmaceuticals

Trade Overview

Capital Trend

News

Comments